19
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Activities of key glycolytic enzymes in the plasma of Saudi autistic patients

, , &
Pages 49-57 | Published online: 13 Apr 2010

References

  • Gillberg C, Coleman M. The Biology of the Autistic Syndromes. Cambridge, MA: MacKeith-Cambridge University Press; 2000.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC: American Psychiatric Association; 1994.
  • Smeeth L, Cook C, Fombonne E, et al. Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001. BMC Med. 2004;2:39.
  • Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. The incidence of autism in Olmsted County, Minnesota, 1976–1997: results from a population-based study. Arch Pediatr Adolesc Med. 2005;159:37–44.
  • Blaxill MF. What’s going on? The question of time trends in autism. Public Health Rep. 2004;119:536–551.
  • Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord. 2002;32: 207–215.
  • Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr. 2005;94:2–15.
  • Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place. 2006;12:203–209.
  • Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006; 91:8–15.
  • Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One. 2008;3(11):3815.
  • Al-Mosalim O, El-Ansary A, Attas O, Al-Ayadhi L. Selected enzymes related to energy metabolism in Saudi autistic children. Clin Biochem. 2009;42:949–957.
  • Chih CP, Roberts Jr EL. Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron Lac shuttle hypothesis. J Cereb Blood Flow Metab. 2003;23:1263–1281.
  • Dienel GA, Hertz L. Glucose and lactate metabolism during brain activation. J Neurosci Res. 2001;66(5):824–838.
  • Cerdán S, Rodrigues TB, Sierra A, et al. The redox switch/redox coupling hypothesis. Neurochem Int. 2006;48(6–7):523–530.
  • Bolaños JP, Peuchen S, Heales SJR, Land JM, Clark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem. 1994;63:910–916.
  • Almeida A, Moncada S, Bolaños JP. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol. 2004;6:45–51.
  • Bigl M, Bruckner MK, Arendt T, Bigl V, Eschrich K. Activities of key glycolytic enzymes in the brains of patients with Alzheimer’s disease. J Neural Transm. 1999;106:499–511.
  • Powers WJ, Videen TO, Markham J, et al. Selective defect of in vivo glycolysis in early Huntington’s disease striatum. Proc Natl Acad Sci U S A. 2007;104:2945–2949.
  • Lehninger AL, Nelson DL. Principles of Biochemistry. New York, NY: Worth Publishers Inc; 1995.
  • Tadeusz KJ. Diagnostic difficulties in pathological fundus changes in the course of combined zygomatico-maxillary fracture. Klin Oczna. 1976;46930:341–345.
  • Selaković V Colić M, Jovanović M, Raicević R, Jovicić A. Cerebrospinal fluid and plasma concentration of soluble intercellular adhesion molecule 1, vascular adhesion molecule 1 and endothelial leukocyte adhesion molecule in patients with acute ischemic brain disease. Voinosanit Pregl. 2003;60(2):139–146.
  • Schaarscmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;25:558–565.
  • Brandt RB, Siegel SA, Waters MG, Bloch MH. Spectrophotometric assay for D-lactate in plasma. Anal Biochem. 1980;102:39–46.
  • Henry JB. Cl in ical D iagnosis and Managem ent by Laboratory Meth ods. Philadelphia, PA: WB Saunders and Company 1979:365.
  • Abrahão-Neto J, Infanti P, Vitolo M. Hexokinase production from S cerevisiae. Culture conditions. Appl Biochem Biotechnol. 1996; 57–58:407–412.
  • Malcovati M, Valentini G. AMP- and Fructose 1,6,-Biphosphate-activated pyruvate kinases from Escherichia coli. Meth Enzymol. 1982;90:170–179.
  • Buonocore G, Perrone S, de Marco L, Valerio Bellieni C. Biomarkers of hypoxic brain injury. In: Ali Qureshi G, Hasan Parvez S, editors. Oxidative Stress andNeurodegenerative Disorders. Maryland Heights, MO: Elsevier; 2007;699–718.
  • Berger RP, Kochanek PM, Pierce MI. Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury? Child Abuse Negl. 2004;28:739–754.
  • Schurr A, Payne RS. Lactate, not pyruvate, is neuronal aerobic glycolysis end product: an in vitro electrophysiological study. Neuroscience. 2007;147:613–619.
  • Ide K, Secher NH. Cerebral blood flow and metabolism during exercise. Prog Neurobiol. 2000;61:397–414.
  • Atlante A, de Bari L, Bobba A, Marra E, Passarella S. Transport and metabolism of L-lactate occur in mitochondria from cerebellar granule cells and are modified in cells undergoing low potassium dependent apoptosis. Biochim Biophys Acta. 2007;1767:1285–1299.
  • Schurr A. Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab. 2006;26:142–152.
  • Homem de Bittencourt PI, Peres CM, Yano MM, Hiratea MH, Curi R. Pyruvate is a lipid precursor for rat lymphocytes in culture: Evidence for a lipid exporting capacity. Biochem Mol Biol Int. 1993; 30:631–641.
  • Kondoh H, Lieonart ME, Gil J, Beach D, Peters G. Glycolysis and cellular immortalization. Drug Discov Today. 2005;2:263–267.
  • Kondoh H, Lieonart ME, Bernard D, Gil J. Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol. 2007;22:85–90.
  • Prichard J, Rothman D, Novotny E, et al. Lac rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci USA. 1991;88:5829–5831.
  • Pellerin L. Lac as a pivotal element in neuron-glia metabolic cooperation. Neurochem Int. 2003;43:331–338.
  • Lü L, Li J, Yew DT, Rudd JA, Mak YT. Oxidative stress on the astrocytes in culture derived from a senescence accelerated mouse strain. Neurochem Int. 2008;52:282–289.
  • Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L. Oxidative stress and antioxidant status in Saudi autistic children. Clin. Biochem. 2009;42:1032–1040.
  • Colell A, Ricci JE, Tait S, et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell. 2007;129:983–997.
  • Gomez A, Ferrer I. Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex of Lewy body diseases. J Neurosci Res. 2009;87(4):1002–1013.
  • Czub E, Herzig KH, Szaflarska-Popawska A, et al. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42(10): 1147–1150.
  • El-Ansary A, Al-Daihan S, Al-Dbbas A, Al-Ahyadi L. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin Biochem. 2010;43(1–2):63–70.
  • Lachant NE, Tomoda A, Tanaka KR. Inhibition of pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood. 1984;63:518–524.
  • Paglia DE, Valentine WN, Dahlgren JG. Effects of low-level lead exposure on pyrimidine-5-nucleotidase and other erythrocyte enzymes, possible role of pyrimidine-5-nucleotidase in the pathogenesis of lead-induced anemia. J Clin Invest. 1975;56:1164–1169.
  • Hunaiti AA, Soud M. Effect of lead concentration on the level of glutathione, glutathione S-transferase, reductase and peroxidase in human blood. Sci Total Environ. 2000;248(1):45–50.